Ligand profile
PDG
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04181 — Aspartate aminotransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
PDG- PDB
1x2a- UniProt (similar protein)
P00509- Target protein
- KP13_04181
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 186.5
- −1 ≤ LogP ≤ 5 0.11
- MW ≤ 500 Da 378.3
- LogP ≤ 5 0.11
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 10
- TPSA ≤ 140 Ų 186.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(c(c(cn1)COP(=O)(O)O)CN[C@H](CCC(=O)O)C(=O)O)OCc1c(c(c(cn1)COP(=O)(O)O)CN[C@H](CCC(=O)O)C(=O)O)O
InChI=1S/C13H19N2O9P/c1-7-12(18)9(8(4-14-7)6-24-25(21,22)23)5-15-10(13(19)20)2-3-11(16)17/h4,10,15,18H,2-3,5-6H2,1H3,(H,16,17)(H,19,20)(H2,21,22,23)/t10-/m1/s1InChI=1S/C13H19N2O9P/c1-7-12(18)9(8(4-14-7)6-24-25(21,22)23)5-15-10(13(19)20)2-3-11(16)17/h4,10,15,18H,2-3,5-6H2,1H3,(H,16,17)(H,19,20)(H2,21,22,23)/t10-/m1/s1
JMRKOGDJNHPMHS-SNVBAGLBSA-NJMRKOGDJNHPMHS-SNVBAGLBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00155
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PDG →
- PDB RCSB structure 1x2a →
- UniProt UniProt P00509 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PDG”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04181.
PDB 38
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).